TWENTY years ago, O Keefe and Marks examined the
|
|
- Vivian Stafford
- 5 years ago
- Views:
Transcription
1 X/98/$03.00/0 Vol. 83, No. 3 Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright 1998 by The Endocrine Society Gin and Tonic and Reactive Hypoglycemia: What Is Important the Gin, the Tonic, or Both?* DANIEL FLANAGAN, PETER WOOD, ROBERT SHERWIN, KWASI DEBRAH, AND DAVID KERR Metabolism Unit, Royal Bournemouth Hospital, Bournemouth, England; Endocrinology Laboratory, Southampton General Hospital (P.W.), and the Division of Endocrinology, Yale University School of Medicine (R.S.), New Haven, Connecticut TWENTY years ago, O Keefe and Marks examined the metabolic consequences of drinking two or three large gin and tonics as a liquid lunch. The combination of gin and a mixer of regular tonic containing 60 g sucrose caused profound reactive hypoglycemia (mean blood glucose nadir, 2.7 mmol/l) up to 3 4 h afterward. Mixing alcohol with low calorie tonic or drinking regular tonic on its own had much less of an effect on blood glucose levels (1). The aim of this study was to test the hypothesis that hypoglycemia occurs not only as a result of hyperinsulinemia but also because of blunting of normal counterregulatory hormone release. Methods Eight healthy volunteers (five men and three women, aged yr), whose weekly alcohol consumption was less than 14 U, gave written consent for the study, which was approved by the local hospital ethics committee. After an overnight fast, 3 days of abstention from alcohol, and resting semirecumbent for 30 min, a retrograde, venous catheter was inserted into the dorsum of the nondominant hand with the hand placed in a hot box at 60 C to arterialize venous blood. The cannula was kept patent with a constant infusion of 0.9% saline. Using a randomized, double blind design, each subject participated in three studies separated by at least 2 weeks. They drank 1) 730 ml regular Indian tonic water ABSTRACT The objectives of this study were to test the hypothesis that alcohol can cause reactive hypoglycemia by attenuating the release of counterregulatory hormones. The subjects were eight healthy volunteers (five men and three women, aged yr). Each subject drank, using a randomized, double blind design 1) three large gin with regular tonics (0.5 g/kg alcohol and 60 g carbohydrate, mainly sucrose (G T); 2) the same amount of alcohol with Slim-line tonic (0.5 g carbohydrate; G alone); and 3) regular tonic without alcohol (T alone). Glucose, insulin, and counterregulatory hormone levels and middle cerebral artery velocity (MCAV), an index of cerebral blood flow, were measured. Alcohol levels averaged mg/dl. Peak insulin levels were similar in both studies in which regular tonic was consumed (95% confidence interval for difference, 6 to22 U/mL). After the ingestion of G T, the blood glucose nadir was lower compared to that with T alone (3.35 vs mmol/l; P 0.02) or G alone (3.35 vs mmol/l; P 0.01). After drinking gin, subjects reported typical hypoglycemic warning symptoms unrelated to the prevailing glucose level. In both alcohol studies, there was marked blunting of GH release (P 0.01). Despite a blood glucose nadir of 3.35 mmol/l, plasma epinephrine levels rose only slightly from 267 to 455 pmol/l (P NS) after G T. Ingestion of alcohol also caused a transient rise in right MCAV (P 0.05) followed by a late drop in velocity in both cerebral hemispheres in the G T study (P 0.05). In otherwise healthy individuals a combination of gin and regular tonic can induce reactive hypoglycemia. Acute ingestion of alcohol impairs the epinephrine response and markedly suppresses the release of GH in response to a fall in blood glucose levels. (J Clin Endocrinol Metab 83: , 1998) (Sainsbury, London, UK) containing 60 g carbohydrate mainly as sucrose plus 0.5 g/kg ethanol as Beefeater Gin equivalent to 97 ml for a 70-kg man (G T), 2) 730 ml Slim-line tonic (Sainsbury, London, UK) containing 0.5 g carbohydrate plus gin as described above (G alone), and 3) 730 ml regular Indian tonic water containing 60 g carbohydrate alone (T alone). Over the next 300 min, the following measurements were made at 30- to 60-min intervals: 1) blood alcohol by gas liquid chromatography; 2) right and left middle cerebral artery velocity, an index of cerebral blood flow, using a trans-cranial Doppler technique (SciMed, Bristol, UK) (2); 3) heart rate and blood pressure using an oscillometric sphygmomanometer; and 4) levels of plasma insulin and the counterregulatory hormones: catecholamines, GH, and cortisol. Plasma insulin [intraassay coefficient of variation (CV), 7.2% at 14.2 U/mL], cortisol (intraassay CV, 6.8 at 382 nmol/l), GH (intraassay CV, 6.2% at 7.8 U/L), and glucagon (intraassay CV, 10.9% at 40 ng/l) levels were measured by double antibody RIA. Catecholamines were measured by a radioenzymatic technique (Amersham, Arlington Heights, IL; epinephrine intraassay CV, 18% at 46 pg/ml; norepinephrine intraassay CV, 10% at 210 pg/ml). Symptoms of hypoglycemia were also determined. Subjects completed 100 mm visual analogue assessment of symptoms characteristically associated with hypoglycemia (facial flushing, palpitations, tingling, trembling, sweating, hunger, lightheadedness, weakness, anxiety, difficulty concentrating, and tiredness). Whole blood glucose was measured at 15-min intervals by a glucose oxidase method (Yellow Springs Instrument Co., Yellow Springs, OH; interassay CV, 4.0% at 4.2 mmol/l). Received September 4, Revision received November 13, Accepted November 18, Address all correspondence and requests for reprints to: Dr. David Kerr, Metabolism Unit, Royal Bournemouth Hospital, Castle Lane East, Bournemouth, Dorset, England BH7 7DW. diabet@rbch-tr. swest.nhs.uk. * This work was supported by grants from the Wessex Medical Trust and the National Institutes of Health (DK-20495). Statistical analyses Overall differences between serial measurements were examined by summary measures (3). Summary responses for each individual were calculated as the area under the curve. Contrasts in group means were compared by repeated measures ANOVA or, where appropriate, by paired Student s t tests. Where data were not normally distributed, comparisons were made after logarithmic transformation or Wilcoxon 796
2 ALCOHOL AND REACTIVE HYPOGLYCEMIA 797 signed rank tests. Results are expressed as differences between means and 95% confidence intervals (CI). Otherwise, data are shown as the mean se or median (interquartile range). Results Blood glucose, plasma insulin, and levels of counterregulatory hormone levels were similar at the start of each study. After ingestion of gin, blood alcohol levels rose rapidly to 60 5 and 66 6 mg/dl in the G T and G alone studies, respectively. As expected, blood glucose and insulin excursions were more substantial after drinking regular tonic (G T and T alone studies; Fig. 1). However, nadir blood glucose levels were lower after drinking G T compared to either G alone (3.35 vs mmol/l; mean difference, 0.60; 95% CI, 0.41 to 0.79 mmol/l; P 0.01) or T alone (3.35 vs mmol/l; mean difference, 0.52 mmol/l; 95% CI, ; P 0.02; Table 1). Insulin levels were markedly higher in both studies where regular tonic was consumed [peak level after G T, 51 vs. 17 U/ ml; after G alone, 34 U/mL (95% CI, 17 52; P 0.02); peak level after T alone, 43 vs. 17 U/mL; 26 U/mL (95% FIG. 1. Blood glucose (upper panel) and plasma insulin levels at baseline and over the subsequent 300 min. Results are shown as the mean SE. CI, 11 41; P 0.02)]. The rise in plasma insulin levels was similar in the G T and T alone studies (95% CI for difference, 6 to22 U/mL; P NS). Overall epinephrine, norepinephrine, cortisol, and glucagon responses were similar in each of the three studies, whereas plasma GH levels were markedly suppressed by alcohol on both occasions (Table 2 and Fig. 2). Despite a blood glucose nadir of 3.35 mmol/l, plasma epinephrine TABLE 1. Glucose nadirs for each individual for the three studies Subject no. G T (mmol/l) G alone (mmol/l) T alone (mmol/l) (225) 3.91 (240) 4.13 (180) (165) 3.94 (285) 3.28 (195) (210) 3.74 (195) 3.29 (195) (195) 3.83 (225) 3.91 (195) (210) 3.89 (210) 3.29 (195) (135) 3.9 (255) 4.17 (150) (90) 3.83 (210) 4.41 (195) (165) 4.5 (270) 4.8 (165) The time of glucose nadir in minutes from starting the drink is shown in parentheses.
3 798 FLANAGAN ET AL. JCE&M 1998 Vol 83 No 3 TABLE 2. Hormonal counterregulatory responses Area under curve Peak levels 95% CI for differences between studies Adrenaline (pmol/l) G T G T vs. G alone, 17 to 286 G alone G T vs. T alone, 85 to 279 T alone G alone vs. T alone, 37 to 112 Noradrenaline (pmol/l) G T G T vs. G alone, 49 to 177 G alone G T vs. T alone, 116 to 156 T alone G alone vs. T alone, 126 to 38 Glucagon (ng/l) G T G T vs. G alone, 10 to 15 G alone G T vs. T alone, 9 to17 T alone G alone vs. T alone, 9 to11 Cortisol (nmol/l) G T G T vs. G alone, 13 to 173 G alone G T vs. T alone, 18 to 168 T alone G alone vs. T alone, 66 to 76 Results expressed as the geometric means of calculated area under curves and peak hormone levels SE. Comparisons between studies are shown as 95% confidence intervals (CI) for differences between peak levels. GH values are shown in Fig. 3. FIG. 2. Plasma GH levels at baseline and over the subsequent 300 min. Results are shown as the mean SE. levels only increased from 267 to 455 pmol/l ( 178 pmol/l; CI, 20 to 395; P NS) and were unchanged from baseline in the other two studies. Levels of other counterregulatory hormones and norepinephrine were similar in all three studies. In both alcohol studies, there was a transient rise in right middle cerebral artery velocity followed by a late fall in velocity in both hemispheres in the G T study (Fig. 3). Drinking G T was also associated with a greater rise in heart rate [after G alone: 11.3 vs. 6.8; 4.5 beats/min (CI, ); after T alone: 11.3 vs. 5.1; 6.2 beats/min; (CI, ; both P 0.05)] and fall in mean arterial pressure [after G alone: 10 vs. 6; 4 mm Hg; (CI, 2 to 7); after T alone: 10 vs. 5; 5 mm Hg; (CI, 1 to 7; both P 0.05)]. After alcohol, the subjects reported an increase in dizziness, tingling, difficulty thinking, and sweating symptoms unrelated to the prevailing blood glucose level, with cumulative symptom scores greater in both alcohol studies (533 and 511 vs. 283 in the Talone study; P 0.01) Discussion Almost 20 yr ago, O Keefe and Marks reported that drinking a combination of gin and regular tonic (equivalent to three double measures) could cause reactive hypoglycemia many hours later, possibly as a result of direct priming of pancreatic -cells by alcohol (1). Here, we have confirmed their original observation that a combination of alcohol and a mixer containing a large amount of carbohydrate is more likely to cause reactive hypoglycemia than drinking either the gin or the mixer on its own. This did not appear to be due to greater hyperinsulinemia. In both alcohol studies, there was marked suppression of plasma GH levels when blood glucose declined below baseline. Drinking gin and regular tonic also caused an early transient rise in heart rate and fall in blood pressure and a later reduction in arterial velocity in both hemispheres. Previous studies have reported that acute and sustained alcohol use can suppress GH release in response to insulininduced hypoglycemia, arginine, and propranolol-glucagon (4 6). At night, acute and chronic alcohol adminis-
4 ALCOHOL AND REACTIVE HYPOGLYCEMIA 799 FIG. 3. Changes in right (upper panel) and left middle cerebral artery velocity. Results are expressed as the percent change SE from baseline for each study. *, P 0.05 for G T and G alone studies vs. T alone; #, P 0.05 for G T vs. G alone and T alone. tration is associated with a 75% reduction in the usual nighttime sleep-related release of GH (7). GH is an insulin antagonist; suppression may therefore lead to increased insulin sensitivity and a lower blood glucose level. Furthermore, after gin and regular tonic, plasma epinephrine levels did not rise significantly despite a blood glucose nadir below the blood glucose threshold for release of epinephrine (8). In healthy volunteers, it would be anticipated that there would be a 3- to 4-fold increase in epinephrine levels associated with the degree of hypoglycemia achieved here (9). However, we cannot entirely confirm the apparent lack of response, as comparable hypoglycemia was not achieved in each individual. After acute ingestion of moderate amounts of alcohol, most studies have shown an increase in heart rate, probably as a reflex response to arteriolar or venous dilatation (10). As noted by others (11, 12), acute ingestion of alcohol caused a transient rise in right middle cerebral artery velocity, an index of cerebral blood flow. The reduction in MCAV occurred around the same time as blood glucose levels fell below baseline and thus could be considered maladaptive, as it would be expected that cerebral blood flow would be maintained in the face of systemic hypoglycemia to maintain substrate supply to the brain. All three drinks contained quinine, which has been implicated in causing hypoglycemia (13), but the dose was small (59 mg/drink) and unlikely to be significant. In conclusion, drinking a combination of gin and regular tonic can cause a fall in blood glucose levels into the hypoglycemic range associated with suppression of GH release. It is possible that the involvement of alcohol in road traffic and other accidents may be a consequence of neuroglycopenia as well as a result of the well recognized direct effects of acute ingestion of alcohol on the brain. Acknowledgments The authors thank Aida Grossman for help with measurement of plasma catecholamine levels, and June Murphy for her assistance with the smooth running of the studies.
5 800 FLANAGAN ET AL. JCE&M 1998 Vol 83 No 3 References 1. O Keefe SJD, Marks V Lunchtime gin and tonic a cause of reactive hypoglycaemia. Lancet. 1: Aaslid R, Markwalder TM, Nornes H Noninvasive transcutaneous doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg. 57: Matthews JNS, Altman DG, Campbell MJ, Royston P Analysis of serial measurements in medical research. Br Med J. 300: Priem HA, Shanley BC, Malan C Effect of alcohol administration on plasma growth hormone response to insulin-induced hypoglycaemia. Metabolism. 25: Kolaczynski JW, Ylikahri R, Harkonen M, Koivisto VA The acute effect of ethanol on counterrgulatory response and recovery from insulin-induced hypoglycaemia. J Clin Endocrinol Metab. 67: Redmond GP Effect of ethanol on endogenous rhythms of growth hormone secretion. Alcoholism Clin Exp Res. 4: Prinz PN, Roehrs TA, Vitaliano PP, Linnoila M, Weitzman Effect of alcohol on sleep and nighttime plasma growth hormone and cortisol concentrations. J Clin Endocrinol Metab. 51: Mitrakou A, Ryan C, Veneman T, et al Hierarchy of thresholds for activation of counterregulatory hormone secretion, symptoms and cerebral dysfunction. Am J Physiol. 260:E67 E DeFeo P, Gallai V, Mazzotta G, et al Modest decrements in plasma glucose concentration cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycaemic symptoms in normal man. J Clin Invest. 82: Stott DJ, Ball SG, Inglis GC, et al Effects of a single moderate dose of alcohol on blood pressure, heart rate and associated metabolic and endocrine changes. Clin Sci. 73: Wendt PE, Risberg J, Stenberg G, Rosen I, Ingvar DH Ethanol reduces asymmetry of visual rcbf responses. J Cerebral Blood Flow Metab. 14: Tiihonen J, Kuikka J, Hakola P, et al Acute ethanol-induced changes in cerebral blood flow. Am J Psychiatry. 151: White NJ, Warrell DA, Chanthavanich P, et al Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl J Med. 309:61 66.
Methods. Ann Intern Med. 1993;119:
Effect of Caffeine on the Recognition of and Responses to Hypoglycemia in Humans David Kerr, MD; Robert S. Sherwin, MD; Frank Pavalkis, PA-C; Pierre B. Fayad, MD; Lori Sikorski, RN; Frances Rife, RN; William
More informationhypoglycaemia unawareness keystone 18 July 2014
hypoglycaemia unawareness keystone 18 July 2014 Hypoglycaemia unawareness: ( Impaired awareness of hypoglycaemia ) Philip Home Newcastle University Philip Home Duality of interest Manufacturers of glucose-lowering
More informationThe Regulation of Liver Glucose Production and Uptake
The Regulation of Liver Glucose Production and Uptake Vanderbilt University Medical Center Nashville, TN USA Dale Edgerton, PhD An Organ Systems Approach to Experimental Targeting of the Metabolic Syndrome
More informationPancreatic Insulinoma Presenting. with Episodes of Hypoinsulinemic. Hypoglycemia in Elderly ---- A Case Report
2008 19 432-436 Pancreatic Insulinoma Presenting with Episodes of Hypoinsulinemic Hypoglycemia in Elderly ---- A Case Report Chieh-Hsiang Lu 1, Shih-Che Hua 1, and Chung-Jung Wu 2,3 1 Division of Endocrinology
More informationTHE CENTRAL IMPORTANCE of prior hypoglycemia in
0021-972X/01/$03.00/0 Vol. 86, No. 5 The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright 2001 by The Endocrine Society Effects of Morning Hypoglycemia on Neuroendocrine and Metabolic
More informationThe Effect of Evening Alcohol Consumption on Next-Morning Glucose Control in Type 1 Diabetes
Clinical Care/Education/Nutrition O R I G I N A L A R T I C L E The Effect of Evening Alcohol Consumption on Next-Morning Glucose Control in Type 1 Diabetes BENJAMIN C. TURNER, MRCP 1 EMMA JENKINS, BSC
More informationASY-805.1: Insulin Tolerance Test. ASY-805.2: Associated Documents. ASY-805.3: Distribution of Documents. ASY-805.4: Review of Document: a b
ASY-805.1: Insulin Tolerance Test ASY-805.2: Associated Documents a b Handbook page task print-out ASY-805.3: Distribution of Documents Copy No Number Location 1 Quality Centre 2 3.1 W232 3 3.20 W232 Laminated
More informationThese results are supplied for informational purposes only.
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: sanofi-aventis ClinialTrials.gov
More informationHypoglyceamia and Exercise
Hypoglyceamia and Exercise Noreen Barker Diabetes Specialist Nurse May 2016 Hypoglyceamia What is a hypo? Why are we concerned? Signs and symptoms Treatments Causes Hypo unawareness Managing diabetes and
More informationGLP-1 agonists. Ian Gallen Consultant Community Diabetologist Royal Berkshire Hospital Reading UK
GLP-1 agonists Ian Gallen Consultant Community Diabetologist Royal Berkshire Hospital Reading UK What do GLP-1 agonists do? Physiology of postprandial glucose regulation Meal ❶ ❷ Insulin Rising plasma
More informationHYPOGLYCEMIA is a major adverse effect of intensive
0021-972X/99/$03.00/0 Vol. 84, No. 5 The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright 1999 by The Endocrine Society Protective Effect of Insulin against Hypoglycemia- Associated
More informationInsulin Tolerance Test Protocol - RNS Endocrinology
Page 1 of 7 - RNS Endocrinology Test name Insulin tolerance test. Alternate test names. Related Tests. Indication(s) Investigation of the hypothalamic pituitary axis (HPA) with regard to the release of
More informationInsulinoma - 72 hour Fast Protocol - RNS Endocrinology
Page 1 of 9 - RNS Endocrinology Test name 72 hour fast Alternate test names. Related Tests Mixed meal test Indication(s) Differential diagnosis of causes of hypoglycaemia. Hypoglycaemia is rare in persons
More informationKunihiro Suzuki, Daisuke Katsura, Masaaki Sagara, Chie Aoki, Mai Nishida and Yoshimasa Aso. Abstract
CASE REPORT Postprandial Reactive Hypoglycemia Treated with a Low-dose Alpha-glucosidase Inhibitor: Voglibose May Suppress Oxidative Stress and Prevent Endothelial Dysfunction Kunihiro Suzuki, Daisuke
More informationEndocrine topic reviews. Artit Sangkakam, MD 19, september 2013
Endocrine topic reviews Artit Sangkakam, MD 19, september 2013 Hypoglycemia in Non-DM Definition In diabetic mellitus : Plasma glucose 70 mg/dl In Non-diabetic mellitus : Plasma glucose 55 mg/dl Normal
More informationHypoglycemia. When recognized early, hypoglycemia can be treated successfully.
Hypoglycemia Introduction Hypoglycemia is a condition that causes blood sugar level to drop dangerously low. It mostly shows up in diabetic patients who take insulin. When recognized early, hypoglycemia
More informationInsulin Secretion in Diabetes Mellitus
A Role for AlphaAdrenergic Receptors in Abnormal nsulin Secretion in Diabetes Mellitus R. PAUL ROBERTSON, JEFFREY B. HALTER, and DANiEL PORTE, JR. From the University of Washington School of Medicine and
More informationSomatostatin is an endogenous peptide and neurotransmitter
Rapid Publication Somatostatin Impairs Clearance of Exogenous Insulin in Humans ELI IPP, YSEF SINAI, BENJAMIN BAR-Z, RAFAEL NESHER, AND ERL CERASI SUMMARY Somatostatin has been widely used to suppress
More informationPREVENTION OF NOCTURNAL HYPOGLYCEMIA USING PREDICTIVE LOW GLUCOSE SUSPEND (PLGS)
PREVENTION OF NOCTURNAL HYPOGLYCEMIA USING PREDICTIVE LOW GLUCOSE SUSPEND (PLGS) Pathways for Future Treatment and Management of Diabetes H. Peter Chase, MD Carousel of Hope Symposium Beverly Hilton, Beverly
More informationCounterregulatory responses to hypoglycemia in patients with maturity-onset diabetes of the young caused by HNF-1a gene mutations (MODY3)
European Journal of Endocrinology (2001) 144 45±49 ISSN 0804-4643 CLINICAL STUDY Counterregulatory responses to hypoglycemia in patients with maturity-onset diabetes of the young caused by HNF-1a gene
More informationInterpretation and management of fasting hyperglycaemia in adults with Type 1 diabetes using MDI insulin regimen
Interpretation and management of fasting hyperglycaemia in adults with Type 1 diabetes using MDI insulin regimen For many years it was believed that high blood glucose (BG) levels first thing in the morning
More informationNew and Emerging Therapies for Type 2 DM
Dale Clayton MHSc, MD, FRCPC Dalhousie University/Capital Health April 28, 2011 New and Emerging Therapies for Type 2 DM The science of today, is the technology of tomorrow. Edward Teller American Physicist
More informationHypoglycaemic disorders
Hypoglycaemic disorders 1. Hypoglycaemia in patients with diabetes mellitus 2. Hypoglycaemia in non-diabetic patients 3. Clinical, laboratory and imaging diagnosis 4. Case report 5. GLP-1 receptor scintigraphy
More informationCounterregulation in Man
Mechanisms of Postprandial Glucose Counterregulation in Man PHYSIOLOGIC ROLS OF GLUCAGON AND PINPHRIN VIS-A-VIS INSULIN IN TH PRVNTION OF HYPOGLYCMIA LAT AFTR GLUCOS INGSTION THOMAS F. TS, WILLIAM. CLUTTR,
More informationFundamentals of Exercise Physiology and T1D
COMPLIMENTARY CE Fundamentals of Exercise Physiology and T1D Jointly Provided by Developed in collaboration with 1 INTRODUCTION TO PHYSICAL ACTIVITY AND T1D 2 Many People with T1D Have Lower Levels of
More informationThe oral meal or oral glucose tolerance test. Original Article Two-Hour Seven-Sample Oral Glucose Tolerance Test and Meal Protocol
Original Article Two-Hour Seven-Sample Oral Glucose Tolerance Test and Meal Protocol Minimal Model Assessment of -Cell Responsivity and Insulin Sensitivity in Nondiabetic Individuals Chiara Dalla Man,
More information28 Regulation of Fasting and Post-
28 Regulation of Fasting and Post- Prandial Glucose Metabolism Keywords: Type 2 Diabetes, endogenous glucose production, splanchnic glucose uptake, gluconeo-genesis, glycogenolysis, glucose effectiveness.
More informationSUPPLEMENTARY DATA. Supplementary Table S1. Clinical characteristics of the study subjects.*
Supplementary Table S1. Clinical characteristics of the study subjects.* T2D ND n (F/M) 66 (21/45) 25 (7/18) Age (years) 61.8 ± 6.9 49.4 ± 7.3 # Body weight (kg) 95 ± 16 105 ± 13 # Body mass index (kg.
More informationC.G. Fanelli, S. Pampanelli, F. Porcellati, L. Bartocci, L. Scionti, P. Rossetti, G.B. Bolli
Diabetologia (2003) 46:53 64 DOI 10.1007/s00125-002-0948-9 Rate of fall of blood glucose and physiological responses of counterregulatory hormones, clinical symptoms and cognitive function to hypoglycaemia
More informationNovel Formulations to Modify Mealtime Insulin Kinetics
Novel Formulations to Modify Mealtime Insulin Kinetics Alan Krasner, Roderike Pohl, Patrick Simms, Philip Pichotta, Robert Hauser, Errol De Souza Biodel, Inc. Danbury, CT Disclosure All authors are employees
More informationRoles of Circadian Rhythmicity and Sleep in Human Glucose Regulation*
0163-769X/97/$03.00/0 Endocrine Reviews 18(5): 716 738 Copyright 1997 by The Endocrine Society Printed in U.S.A. Roles of Circadian Rhythmicity and Sleep in Human Glucose Regulation* EVE VAN CAUTER, KENNETH
More informationCase study: Adult with uncontrolled type 2 diabetes of long duration and cardiovascular disease
Case study: Adult with uncontrolled type 2 diabetes of long duration and cardiovascular disease Authored by Paul Zimmet and Richard Nesto on behalf of the Global Partnership for Effective Diabetes Management.
More informationHypoglycaemia in an inner-city accident
Archives of Emergency Medicine, 1989, 6, 183-188 Hypoglycaemia in an inner-city accident and emergency department: a 12-month survey M. D. FEHER, P. GROUT, A. KENNEDY, R. S. ELKELES & R. TOUQUET Departments
More informationPediatric Toxic Hypoglycemia. Sara Kazim, MD, FRCP (EM) Clinical Pharmacology and Medical Toxicology Fellowship IEMC May Antalya
Pediatric Toxic Hypoglycemia Sara Kazim, MD, FRCP (EM) Clinical Pharmacology and Medical Toxicology Fellowship IEMC May 2016 - Antalya Conflicts of Interests... None Learning Needs... By the end of this
More informationDiabetes in the Elderly 1, 2, 3
Diabetes in the Elderly 1, 2, 3 WF Mollentze Feb 2010 Diabetes in the elderly differs from diabetes in younger people Prevalence: o Diabetes increases with age affecting approximately 10% of people over
More informationEffect of sex on counterregulatory responses to exercise after antecedent hypoglycemia in type 1 diabetes
Am J Physiol Endocrinol Metab 287: E16 E24, 2004. First published March 2, 2004; 10.1152/ajpendo.00480.2002. Effect of sex on counterregulatory responses to exercise after antecedent hypoglycemia in type
More informationOlympic diabetes What have we learned over the last decade? Ian Gallen Jephcott Symposium 9 th May 2012
Olympic diabetes What have we learned over the last decade? Ian Gallen Jephcott Symposium 9 th May 2012 Diabetes and exercise Ian Gallen Challenges in the management SR s diabetes prior to 2000 Olympic
More information7/28/17. Objectives: Hypoglycemia Unawareness in the Geriatric Patient: A Safety Concern. Disclaimer:
Hypoglycemia Unawareness in the Geriatric Patient: A Safety Concern 29TH ANNUAL TNP CONFERENCE TRANSFORMING HEALTHCARE IN TEXAS SEPTEMBER 8, 2017 AUSTIN, TEXAS Kenneth Lowrance, DNP, APRN, CNS, FNP-BC,
More informationTYPE 2 DIABETES AND STEROID TABLETS
MEDICATION TYPE 2 DIABETES AND STEROID TABLETS WHY IS THIS LEAFLET FOR YOU? Taking steroid treatment when you have diabetes can make your blood glucose levels more difficult to control. This leaflet will
More informationManaging Endocrine Related Issues after Bariatric Surgery. Jenny Tong, MD, MPH Division of Endocrinology March 3, 2018
Managing Endocrine Related Issues after Bariatric Surgery Jenny Tong, MD, MPH Division of Endocrinology March 3, 2018 Bariatric Surgery was Associated with Higher Remission Rate than Usual Care 72.3% 38.1%
More informationChief of Endocrinology East Orange General Hospital
Targeting the Incretins System: Can it Improve Our Ability to Treat Type 2 Diabetes? Darshi Sunderam, MD Darshi Sunderam, MD Chief of Endocrinology East Orange General Hospital Age-adjusted Percentage
More informationChristine Pelkman, PhD
Christine Pelkman, PhD Dr. Pelkman is a graduate faculty member in Nutrition, and Director of the Nutrition and Health Research Laboratory at the University of Buffalo. She completed her doctoral and postdoctoral
More information7/31/2009. G.Y. Prince Used Cars 10 am Los Angelos, CA Mullholland Drive..later that day. Would you buy a car without taking it for a spin first?
7/31/29 My Anna will love it! Who needs a test drive? Or a Warranty? It looked great in the lot! Do mean to say that you never actually test drove the car? G.Y. Prince Used Cars 1 am Los Angelos, CA Mullholland
More informationESPEN Congress Madrid 2018
ESPEN Congress Madrid 2018 Dysglycaemia In Acute Patients With Nutritional Therapy Mechanisms And Consequences Of Dysglycaemia In Patients Receiving Nutritional Therapy M. León- Sanz (ES) Mechanisms and
More informationFreeStyle Mini Blood Glucose Results Are Accurate and Suitable for Use in Glycemic Clamp Protocols
Journal of Diabetes Science and Technology Volume 2, Issue 5, September 2008 Diabetes Technology Society CLINICAL APPLICATIONS FreeStyle Mini Blood Glucose Results Are Accurate and Suitable for Use in
More informationIncreasing the Decrement in Insulin Secretion Improves Glucagon Responses to Hypoglycemia in Advanced Type 2 Diabetes
Emerging Treatments and Technologies O R I G I N A L A R T I C L E Increasing the Decrement in Insulin Secretion Improves Glucagon Responses to Hypoglycemia in Advanced Type 2 Diabetes ZARMEN ISRAELIAN,
More informationRole of incretins in the treatment of type 2 diabetes
Role of incretins in the treatment of type 2 diabetes Jens Juul Holst Department of Medical Physiology Panum Institute University of Copenhagen Denmark Diabetes & Obesity Spanish Society of Internal Medicine
More informationGlucagon response to hypoglycemia in sympathectomized man.
Glucagon response to hypoglycemia in sympathectomized man. J P Palmer,, D G Johnson, J W Ensinck J Clin Invest. 1976;57(2):522-525. https://doi.org/10.1172/jci108305. Research Article Hypoglycemia stimulates
More informationEffect of morning exercise on counterregulatory responses to subsequent, afternoon exercise
J Appl Physiol 91: 91 99, 2001. Effect of morning exercise on counterregulatory responses to subsequent, afternoon exercise PIETRO GALASSETTI, STEPHNIE MANN, DONNA TATE, RAY A. NEILL, DAVID H. WASSERMAN,
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Baidal DA, Ricordi C, Berman DM, et al. Bioengineering of an
More informationTestosterone Therapy in Men An update
Testosterone Therapy in Men An update SANDEEP DHINDSA Associate Professor of Medicine Director, Division of Endocrinology and Metabolism, Saint Louis University, St. Louis, MO Presenter Disclosure None
More informationHypoglycemic episodes developing during nocturnal
Brief Report Awakening and Counterregulatory Response to Hypoglycemia During Early and Late Sleep Kamila Jauch-Chara, 1 Manfred Hallschmid, 2 Steffen Gais, 2 Kerstin M. Oltmanns, 3 Achim Peters, 1 Jan
More information15 th Annual DAFNE collaborative meeting Tuesday 28 th June 2016
15 th Annual DAFNE collaborative meeting Tuesday 28 th June 2016 Sponsored by: Abbott Diabetes Care and Lilly Diabetes Type 1 and exercise Royal Berkshire Hospital Centre for Diabetes and Endocrinology
More informationThe second meal phenomenon in type 2 diabetes
Diabetes Care Publish Ahead of Print, published online April 14, 2009 Second meal phenomenon and diabetes The second meal phenomenon in type 2 diabetes Ana Jovanovic MD, Jean Gerrard SRN, Roy Taylor MD
More informationDiabetologia. Key words: Catecholamines, cortisol, glucagon, glucose counter-regulation, growth hormone, hypoglycaemia. Subjects and Protocols
Diabetologia (1982) 22:100-105 Diabetologia 9 Springer-Verlag 1982 Lack of Glucagon Response in Glucose Counter-Regulation in Type 1 (Insulin-Dependent) Diabetics: Absence of Recovery After Prolonged Optimal
More informationC-Peptide and Exercise in people with Type 1 Diabetes. Guy Taylor
C-Peptide and Exercise in people with Type 1 Diabetes Guy Taylor Produced in equal amounts to insulin C-Peptide Used to assess endogenous insulin secretion not injected with exogenous insulin Pathogenesis
More informationDiabetologia 9 Springer-Verlag 1984
Diabetologia (1984) 26:203 207 Diabetologia 9 Springer-Verlag 1984 How does glucose regulate the human pancreatic A cell in vivo? C. M. Asplin*, P. M. Hollander** and J. P. Palmer Diabetes Research Center
More informationPresented by Dr. Bruce Perkins, MD MPH Dr. Michael Riddell, PhD
Type 1 Diabetes and Exercise: Optimizing the Medtronic MiniMed Veo Insulin Pump and Continuous Glucose Monitoring (CGM) for Better Glucose Control 1,2 for Healthcare Professionals Presented by Dr. Bruce
More informationnorepinephrinee." 2 PNMT activity is stimulated by certain adrenocortical markedly,3' 4 but can be restored to normal by the administration of
IMPAIRED SECRETION OF EPINEPHRINE IN RESPONSE TO INSULIN AMONG HYPOPHYSECTOMIZED DOGS* BY RICHARD J. WURTMAN, ALFRED CASPER, LARISSA A. POHORECKY, AND FREDERIC C. BARTTER DEPARTMENT OF NUTRITION AND FOOD
More informationUNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY
1 UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY GLUCOSE HOMEOSTASIS An Overview WHAT IS HOMEOSTASIS? Homeostasis
More informationSubcutaneous exendin (9-39) effectively treats post-bariatric hypoglycemia
Subcutaneous exendin (9-39) effectively treats post-bariatric hypoglycemia C OLLEEN M. CRAIG, M.D. T RACEY L. MC L AUGHLIN, M.D., M.S. Division of Endocrinology, Metabolism & Gerontology Stanford University
More informationThe In-Clinic Close Loop Experience in the US
The In-Clinic Close Loop Experience in the US Keystone Symposium, Practical Ways to Achieve Targets in Diabetes Care July 14, 2012 Francine Ratner Kaufman, MD Chief Medical Officer, VP Global Medical,
More informationNormal Fuel Metabolism Five phases of fuel homeostasis have been described A. Phase I is the fed state (0 to 3.9 hours after meal/food consumption),
Normal Fuel Metabolism Five phases of fuel homeostasis have been described A. Phase I is the fed state (0 to 3.9 hours after meal/food consumption), in which blood glucose predominantly originates from
More informationWhat systems are involved in homeostatic regulation (give an example)?
1 UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY GLUCOSE HOMEOSTASIS (Diabetes Mellitus Part 1): An Overview
More informationIntroduction. The oxytocin/ / vasopressin receptor antagonist, atosiban, delays the gastric emptying of a semisolid meal compared to saline in human
The oxytocin/ / vasopressin receptor antagonist, atosiban, delays the gastric emptying of a semisolid meal compared to saline in human Bodil Ohlsson, et. al., Sweden BMC Gastroenterology, 2006 Presented
More informationLearning Objectives. At the conclusion of this module, participants should be better able to:
Learning Objectives At the conclusion of this module, participants should be better able to: Treat asymptomatic neonatal hypoglycemia with buccal dextrose gel Develop patient-specific approaches to intravenous
More informationβ 2 -Adrenergic receptor agonist administration promotes counter-regulatory responses and recovery from hypoglycaemia in rats
DOI 10.1007/s00125-013-3009-7 ARTICLE β 2 -Adrenergic receptor agonist administration promotes counter-regulatory responses and recovery from hypoglycaemia in rats Barbara Szepietowska & Wanling Zhu &
More informationInsulin Stress Test. An information guide
TO PROVIDE THE VERY BEST CARE FOR EACH PATIENT ON EVERY OCCASION Insulin Stress Test An information guide Insulin Stress Test Your doctor or nurse has recommended that you have an insulin stress test.
More informationSupplementary Figure 1: Steviol and stevioside potentiate TRPM5 in a cell-free environment. (a) TRPM5 currents are activated in inside-out patches
Supplementary Figure 1: Steviol and stevioside potentiate TRPM5 in a cell-free environment. (a) TRPM5 currents are activated in inside-out patches during application of 500 µm Ca 2+ at the intracellular
More informationSitagliptin: first DPP-4 inhibitor to treat type 2 diabetes Steve Chaplin MSc, MRPharmS and Andrew Krentz MD, FRCP
Sitagliptin: first DPP-4 inhibitor to treat type 2 diabetes Steve Chaplin MSc, MRPharmS and Andrew Krentz MD, FRCP KEY POINTS sitagliptin (Januvia) is a DPP-4 inhibitor that blocks the breakdown of the
More informationAetna Better Health of Virginia
Genotropin Nutropin Serostim Zomacton Humatrope Omnitrope Zorbtive somatropin Norditropin Saizen General Criteria for Approval: Omnitrope vial formulation is the preferred Growth Hormone product; consideration
More informationManagement of Type 2 Diabetes
Management of Type 2 Diabetes Pathophysiology Insulin resistance and relative insulin deficiency/ defective secretion Not immune mediated No evidence of β cell destruction Increased risk with age, obesity
More informationHYPOGLYCEMIA and neuroglycopenic symptoms
0021-972X/00/$03.00/0 Vol. 85, No. 9 The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright 2000 by The Endocrine Society Forty-Eight-Hour Fast: The Diagnostic Test for Insulinoma
More informationHypoglycemia in congenital hyperinsulinism
How a normal body works: Our body is constantly at work. Our cells need a source of energy, and this source of energy is called glucose. The process is quite simple; think of it like an assembly line.
More informationPathogenesis of Type 2 Diabetes
9/23/215 Multiple, Complex Pathophysiological Abnmalities in T2DM incretin effect gut carbohydrate delivery & absption pancreatic insulin secretion pancreatic glucagon secretion HYPERGLYCEMIA? Pathogenesis
More informationGlucagon secretion in relation to insulin sensitivity in healthy subjects
Diabetologia (2006) 49: 117 122 DOI 10.1007/s00125-005-0056-8 ARTICLE B. Ahrén Glucagon secretion in relation to insulin sensitivity in healthy subjects Received: 4 July 2005 / Accepted: 12 September 2005
More informationAtropine in Down's Syndrome
Archives of Disease in Childhood, 1971, 46, 61. Response to Atropine in G. H. MIR and GORDON R. CUMMING From The Clinical Investigation Unit, Children's Hospital of Winnipeg, and The Department of Pediatrics,
More informationSupplementary Online Content
Supplementary Online Content Larsen JR, Vedtofte L, Jakobsen MSL, et al. Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia
More informationStaying safe on an insulin pump
Staying safe on an insulin pump Exceptional healthcare, personally delivered Insulin pump therapy is a safe and effective way of treating diabetes. However due to the way the insulin is delivered, problems
More informationRecognising, managing and preventing hypoglycaemia
CPD Module Recognising, managing and preventing hypoglycaemia Debbie Hicks Since the discovery of insulin by Banting and Best in 1922, there have been a number of important developments in the treatment
More informationWARD INSTRUCTIONS WEBSITE
DEPARTMENT OF CLINICAL CHEMISTRY NEW CROSS HOSPITAL WOLVERHAMPTON WARD INSTRUCTIONS WEBSITE Edition 1.1 SOP E1.120P.CHE Date issued: June 2016 Review interval: Authorised copy: Printed copies Author Location
More informationThe artificial pancreas: the next step in connectivity and digital treatment of type 1 diabetes
The artificial pancreas: the next step in connectivity and digital treatment of type 1 diabetes Roman Hovorka PhD FMedSci University of Cambridge, UK Duality of interest declaration Advisory Panel: Research
More informationDr John Quin. Royal Sussex County Hospital, Brighton. BHIVA AUTUMN CONFERENCE 2013 Including CHIVA Parallel Sessions. None
BHIVA AUTUMN CONFERENCE 2013 Including CHIVA Parallel Sessions Dr John Quin Royal Sussex County Hospital, Brighton COMPETING INTEREST OF FINANCIAL VALUE > 1,000: Speaker Name Statement Dr John Quin None
More informationIatrogenic hypoglycemia is the limiting factor in the
Sleep-Related Hypoglycemia-Associated Autonomic Failure in Type 1 Diabetes Reduced Awakening From Sleep During Hypoglycemia Salomon Banarer and Philip E. Cryer Given that iatrogenic hypoglycemia often
More informationMental Health: Where Nutrition meets Psychiatry By Nicola Walters, Registered Dietitian
Mental Health: Where Nutrition meets Psychiatry By Nicola Walters, Registered Dietitian Key Focus Areas Overview of Global & SA Statistics Analysis of the Evidence Sugar & Refined Carbohydrates Fat: dietary
More informationThese results are supplied for informational purposes only.
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: sanofi-aventis ClinialTrials.gov
More informationبنام خدا هیپوگلیسمی درنوزادان و گاالکتوزمی دکتر انتظاری
بنام خدا هیپوگلیسمی درنوزادان و گاالکتوزمی دکتر انتظاری Serum glucose< 35 mg/dl 1-3 hr of life < 40 mg/dl 3-24 hr < 45 mg/dl after 24 hr 10% NL newborns can t maintain BS>30 if delayed feeding >3-6 hrs
More informationSUPPLEMENTARY DATA. Supplementary Table 1. Baseline Patient Characteristics
Supplementary Table 1. Baseline Patient Characteristics Normally distributed data are presented as mean (±SD), data that were not of a normal distribution are presented as median (ICR). The baseline characteristics
More informationThe Endocrine SyStem. COMMUNICATION System
The Endocrine SyStem COMMUNICATION System Endocrine FACTS The endocrine system is made up of glands that release their products (hormones) directly into the bloodstream. The response of hormones is slower
More informationEndocrine part one. Presented by Dr. Mohammad Saadeh The requirements for the Clinical Chemistry Philadelphia University Faculty of pharmacy
Endocrine part one Presented by Dr. Mohammad Saadeh The requirements for the Clinical Chemistry Philadelphia University Faculty of pharmacy HORMONES Hormones are chemicals released by a cell or a gland
More informationAlternative insulin delivery systems: how demanding should the patient be?
Diabetologia (1997) 4: S97 S11 Springer-Verlag 1997 Alternative insulin delivery systems: how demanding should the patient be? K.S. Polonsky, M. M. Byrne, J. Sturis Department of Medicine, The University
More informationRole of Cortisol in the Pathogenesis of Deficient Counterregulation after Antecedent Hypoglycemia in Normal Humans
Role of Cortisol in the Pathogenesis of Deficient Counterregulation after Antecedent Hypoglycemia in Normal Humans Stephen Neil Davis, Chris Shavers, Fernando Costa, and Rogelio Mosqueda-Garcia Department
More informationHigh and Low GH: an update of diagnosis and management of GH disorders
High and Low GH: an update of diagnosis and management of GH disorders Georgia Chapter-AACE 2017 Laurence Katznelson, MD Professor of Medicine and Neurosurgery Associate Dean of Graduate Medical Education
More informationChecking the Right Box at the Right Age: the Art of Pediatric Endocrine Testing
Checking the Right Box at the Right Age: the Art of Pediatric Endocrine Testing Jean-Pierre Chanoine, MD Endocrinology and Diabetes Unit British Columbia s Children s Hospital Objectives 1. Interpret the
More informationUpdate on diagnosis and complications of adult and elderly male hypogonadism
Hypoandrogenism in the elderly: to treat or not to treat? 12 th Italian AME Meeting; 6 th joint Meeting with AAC Bari november 10th Update on diagnosis and complications of adult and elderly male hypogonadism
More informationWhat is the role of insulin pumps in the modern day care of patients with Type 1 diabetes?
What is the role of insulin pumps in the modern day care of patients with Type 1 diabetes? Dr. Fiona Wotherspoon Consultant in Diabetes and Endocrinology Dorset County Hospital Fiona.Wotherspoon@dchft.nhs.uk
More informationComparison of intramuscular glucagon and intravenous dextrose in the. accident and emergency department. treatment of hypoglycaemic coma in an
Archives of Emergency Medicine, 1990, 7, 73-77 Comparison of intramuscular glucagon and intravenous dextrose in the treatment of hypoglycaemic coma in an accident and emergency department A. W. PATRICK',
More informationDiabetic Ketoacidosis
October 2015 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Case History HPI: 24 yo man with recent 8 lb. weight loss, increased thirst and frequent
More informationINSULIN THERAY دکتر رحیم وکیلی استاد غدد ومتابولیسم کودکان دانشگاه علوم پزشکی مشهد
INSULIN THERAY DIABETES1 IN TYPE دکتر رحیم وکیلی استاد غدد ومتابولیسم کودکان دانشگاه علوم پزشکی مشهد Goals of management Manage symptoms Prevent acute and late complications Improve quality of life Avoid
More informationEvaluation of Endocrine Tests. C: glucagon and clonidine test in phaeochromocytoma
ORIGINAL ARTICLE Evaluation of Endocrine Tests. C: glucagon and clonidine test in phaeochromocytoma P.H. Bisschop 1*, E.P.M. Corssmit 2, S.J. Baas 1, M.J. Serlie 1, E. Endert 3, W.M. Wiersinga 1, E. Fliers
More information